Allurion Technologies, Inc., a Wellesley, MA-based developer of novel medical device technologies, has received a $750k loan from the Massachusetts Life Sciences Center.
The company is using the funds to continue to develop its novel medical device called Allurion, which is designed to induce significant weight loss by displacing volume in the stomach without surgery leveraging super-porous hydrogel technology.
The device, which can be eliminated via an orally available, non-toxic dissolution agent, will target patients across the obesity spectrum.
Allurion Technologies was founded in 2009.
The Massachusetts Life Sciences Center’s Accelerator Program provides loans of up to $750k to early-stage companies engaged in life sciences research and development, commercialization and manufacturing.